GPX3 and inflammatory breast carcinoma: Since almost all IBC patients presented with positive axillary lymph node metastasis [21], herein, we investigated whether expression and epigenetic regulation of GPX3 may contribute to the aggressive phenotype IBC versus non-IBC.